Side-by-side comparison of AI visibility scores, market position, and capabilities
US pharmacy chain that emerged from Chapter 11 bankruptcy (filed October 2023) following $1.3B+ opioid settlements; competing with CVS and Walgreens with a restructured reduced store network.
Rite Aid is a US pharmacy retail chain — historically one of the three largest US drugstore networks alongside CVS and Walgreens — operating neighborhood pharmacies providing prescription medications, immunizations, health screenings, and personal care retail. Founded in 1962 in Scranton, Pennsylvania and headquartered in Camp Hill, Pennsylvania, Rite Aid filed for Chapter 11 bankruptcy protection in October 2023 under the combined pressure of opioid litigation settlements exceeding $1.3 billion, real estate liabilities from 2,200+ store leases, declining pharmacy reimbursement rates from PBMs, and debt from the 2007 acquisition of Eckerd pharmacies. Rite Aid emerged from bankruptcy in 2024 with a restructured balance sheet and reduced store network, closing hundreds of locations while maintaining operations in core markets.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.